Promino Nutritional Sciences Inc.
MUSLF
$0.0442
-$0.0057-11.42%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -9.01% | -49.80% | -77.10% | -88.71% | -94.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.01% | -49.80% | -77.10% | -88.71% | -94.28% |
| Cost of Revenue | -66.02% | -29.53% | -51.41% | -64.39% | -22.91% |
| Gross Profit | 71.86% | 22.76% | 26.24% | -37.97% | -375.76% |
| SG&A Expenses | 209.20% | 13.12% | -23.83% | -55.51% | -58.27% |
| Depreciation & Amortization | -76.92% | -55.74% | -36.96% | -17.56% | -36.24% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 87.54% | 2.05% | -32.46% | -58.58% | -47.64% |
| Operating Income | -91.64% | -5.61% | 24.38% | 46.53% | 19.79% |
| Income Before Tax | -72.11% | 0.62% | 24.11% | 45.40% | 5.81% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -72.11% | 0.62% | 24.11% | 45.40% | 5.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -72.11% | 0.62% | 24.11% | 45.40% | 5.81% |
| EBIT | -91.64% | -5.61% | 24.38% | 46.53% | 19.79% |
| EBITDA | -92.08% | -5.67% | 24.39% | 46.60% | 19.78% |
| EPS Basic | -31.47% | 17.54% | 30.42% | 42.64% | 19.30% |
| Normalized Basic EPS | -41.00% | 10.90% | 24.38% | 36.73% | 19.21% |
| EPS Diluted | -31.47% | 17.54% | 30.42% | 42.64% | 19.30% |
| Normalized Diluted EPS | -41.00% | 10.90% | 24.38% | 36.73% | 19.21% |
| Average Basic Shares Outstanding | 12.09% | 78.97% | 63.76% | 50.16% | 67.43% |
| Average Diluted Shares Outstanding | 12.09% | 78.97% | 63.76% | 50.16% | 67.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
